ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $65,000 | -52.9% | 20,974 | -38.9% | 0.02% | +6.7% |
| Q4 2015 | $138,000 | +193.6% | 34,306 | +236.6% | 0.02% | +200.0% |
| Q3 2015 | $47,000 | -17.5% | 10,191 | -7.5% | 0.01% | -16.7% |
| Q2 2015 | $57,000 | -80.9% | 11,017 | -76.9% | 0.01% | -79.3% |
| Q1 2015 | $299,000 | -5.7% | 47,722 | -5.3% | 0.03% | -3.3% |
| Q4 2014 | $317,000 | +217.0% | 50,403 | +206.5% | 0.03% | +233.3% |
| Q3 2014 | $100,000 | +4.2% | 16,443 | +12.7% | 0.01% | +12.5% |
| Q2 2014 | $96,000 | -91.5% | 14,592 | -83.1% | 0.01% | -83.3% |
| Q2 2013 | $1,136,000 | – | 86,516 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |